Transcript Slide 1
Blood borne viral hepatitis action in Wales Presenter: Dr Marion Lyons, BBV Lead for Wales 2010 Minister for Health announces £1.377 recurrent funding for Blood borne viral Hepatitis Action Plan for Wales Accountability • • • • • • • • Welsh Assembly Government Health Service Planners Health Boards - NSE and health promotion Health Boards - Primary Care Health Boards – Treatment and care Local Authorities The National Offender Management Service Non statutory organisations including patient groups • Public Health Wales Structures Prevention, education and awareness raising Harm reduction database • Lack of evidence re. prevalence of injecting drug use in Wales denominator data required for incidence and modelling potential burden of disease • Evidence of ‘patchy’ NSP provision across Wales • Primary means of accessing, informing and preventing onward transmission amongst most at risk groups • System live in statutory and voluntary sector needle exchange services (including mobile services) 1st September 2010 • To date over 2700 injectors registered • Next steps – roll out in community pharmacy based services Prevention, education and awareness raising • Development of endorsed BBV training programmes: – Level 1 – all individuals working with those currently or potentially at risk of infection with blood borne viruses (HBV, HCV and HIV) – Level 2 – all individuals responsible for diagnosing and treating individuals for blood borne viruses Prevention, education and awareness raising • Ongoing work focusing on: – Improving BBV services for offender populations in Wales – Research project – ‘How best to deliver health care messages re. BBVs’ – Targeted and generic awareness raising programme Diagnosis & Surveillance Dried blood spot testing (DBS) – Pilot study in North West Wales CDT – Means of testing for BBVs without need for venepuncture (in first instance) – Same protocol as utilised in prevalence and incidence study 2005-2007 (700+ current IDUs) – Improved uptake of testing amongst most high risk groups – Behavioural / risk behaviour questionnaire to support evidence of transmission UK wide Diagnosis & Surveillance • Strengthening of existing surveillance systems – e.g. Co-surv • Development of new patient management tools • Active case finding tools in primary care • Data matrix available at: http://www.wales.nhs.uk/sites3/page.cfm ?orgid=457&pid=25483 Treatment and care pathways • Each of seven treatment centres in Wales develop local action plan • Establishment of testing and treatment in Community settings e.g. Drug services, primary care • Development of clinical networks and consensus on treatment for HBV and HCV Stakeholder engagement and events • BBV workshop – 18th Nov 2010 • Aimed to identify existing best practice and areas for improvement • Opportunity to achieve consensus on treatment for BBV hepatitis in Wales – Lead clinicians from all treatment centres in Wales – BBV nurse specialists – BBV Leads from all drug services Stakeholder engagement and events • BBV Action in Wales Conference on World Hepatitis Day July 2011 Open to all stakeholders and interested parties • Progress to date • Areas for improvement • Evaluation of interventions • Next steps Contact details [email protected] [email protected] [email protected] [email protected] Copy of Action Plan available at: http://wales.gov.uk/docs/phhs/publicatio ns/100226actionplanen.pdf